Live Quiz Arena
🎁 1 Free Round Daily
⚡ Enter ArenaQuestion
← Human Body & HealthA patient with a genetic mutation has normal levels of all clotting factors, yet their blood clots very slowly. Which mechanism explains this phenomenon?
A)Reduced thromboxane A2 production
B)Increased antithrombin III activity
C)Defective fibrin cross-linking by FXIII✓
D)Accelerated plasminogen activator activity
💡 Explanation
Defective fibrin cross-linking by Factor XIII leads to unstable clot formation, because it prevents the fibrin mesh from properly stabilizing the platelet plug; therefore, even with normal clotting factor levels, the clot is weak and breaks down quickly, rather than forming a stable, durable barrier.
🏆 Up to £1,000 monthly prize pool
Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.
Related Questions
Browse Human Body & Health →- If a patient with a severe concussion experiences a prolonged metabolic crisis post-injury, which consequence involving glutamate excitotoxicity is most likely, given insufficient energy to maintain ion gradients?
- Why does a higher ventilation-perfusion ratio in the lung apex, compared to the base, contribute to increased susceptibility to tuberculosis (TB) infection in the apex?
- If a long-distance runner on a thiamine-deficient diet experiences muscle weakness and fatigue, which metabolic consequence most directly impairs their performance?
- Why does aggregated alpha-synuclein accumulation in neurons trigger apoptosis rather than proteasomal degradation?
- Why does significant dehydration cause a decrease in sweat rate despite rising core body temperature during prolonged exercise?
- In a patient with type 2 diabetes experiencing insulin resistance, which adaptation initially helps maintain normal blood glucose levels despite reduced insulin sensitivity in peripheral tissues?
